Valery Feigin, a neurologist, clinical epidemiologist and stroke sub-specialist, is the director of AUT’s National Institute for Stroke and Applied Neuroscience (NISAN), the only national research institute solely dedicated to studying the epidemiology and prevention of neurological disorders in New Zealand.

He is also Affiliate Professor of the Department of Global Health at the Institute for Health Metrics and Evaluation at the University of Washington; President of the International Association on Neurology and Epidemiology; Honorary Professor of the Novosibirsk State Medical University, Russia, and Visiting Professor of the Capital Medical University in Beijing, China. He is a Fellow Member (Academic) of the Royal Society of New Zealand, a Foreign Fellow (Academic) of the Russian Academy of Sciences, and a Fellow of the American Academy of Neurology. He is a member of the Advisory Working Group on Stroke for the WHO, WHO Technical Advisory Group on NCD-related Research and Innovation and is currently Co-Chair of the Global Policy Committee and Executive Committee member of the World Stroke Organization.

He graduated in medicine from the Novosibirsk Medical University, Russia (MD, MSc, PhD in Neurology), and undertook advanced training in neurology and clinical epidemiology in Mayo Clinic (USA) and Erasmus University in The Netherlands.